ライフサイエンスコーパス: surgical pathology

1 ving to be a highly significant biomarker in surgical pathology.

2 associated with the presence of unfavorable surgical pathology.

3 e of ages, associated disease processes, and surgical pathology.

4 ent EUS findings did not correlate well with surgical pathology.

5 esponse and EUS staging were correlated with surgical pathology.

6 36 (97.3%) had correct localization based on surgical pathology.

7 arcinoma (OPC) but can only be diagnosed via surgical pathology.

8 tumors from 100 patients were identified on surgical pathology.

9 ith tumor size and lymph node involvement in surgical pathology.

10 ly underwent resection of the large mass and surgical pathology.

11 versus not detected) included larger size at surgical pathology (37 vs 22 mm; P < .001) and axillary

12 f pretreatment functioning (46.4% to 78.4%), surgical pathology (37.1% to 86.3%), radiation technique

13 Surgical pathology after thoracotomy was used as the ref

14 It was decided to rule out surgical pathology and a CT scan was performed finding n

15 lity and diagnostic performance of MRI, with surgical pathology and follow-up electronic records as r

16 Surgical pathology and follow-up revealed 19 patients wi

17 any thickness) may improve the management of surgical pathology and guide microsurgery of any human t

18 of molecular genetics from the laboratory to surgical pathology and other clinical departments is a m

19 ults of the phase II proportion, focusing on surgical pathology and safety outcomes on an exploratory

20 We assessed the relationship between pKIM-1, surgical pathology, and clinical outcomes.

21 , results of cytologic examination of urine, surgical pathology, and total dose and duration of cyclo

22 hese data clearly demonstrate the primacy of surgical pathology as the major determinant of outcome i

23 resection, and these 167 patients had final surgical pathology available.

24 The primary outcome was surgical pathology categorized as (i) viable non-teratom

25 FNAs (23.7%), and all tumors with follow-up surgical pathology confirmed malignancy.

26 reoperative imaging were identified from the surgical pathology database (mean age, 51 years; median,

27 Twenty-four patients with records in the surgical pathology database who had a diagnosis of mamma

28 ologically confirmed DN was identified using surgical pathology databases at the study sites; 590 cas

29 Surgical pathology demonstrated a pCR in 13 of 20 (65%)

30 g nine, seven (77.8%) had a stage I PDAC (by surgical pathology) detected during surveillance; one ha

31 End points were surgical pathology diagnosis/clinical follow-up.

32 iasis, AD, and erythroderma belonging to the surgical pathology files of the James Homer Wright Patho

33 We have reviewed the surgical pathology files of The Johns Hopkins Hospital i

34 y shown more than 80% accuracy compared with surgical pathology for depth of tumor invasion (T).

35 p learning models that have found success in surgical pathology for our cytopathology study.

36 herapy for a variety of commonly encountered surgical pathologies including cardiovascular disease, n

37 f pathology reports and/or central review of surgical pathology materials.

38 Based on 251 (21%) patients with surgical pathology, mitogen-activated protein kinase/GNA

39 Despite a breadth of surgical pathology, neonates share many perioperative pr

40 Surgical pathology of the resected MAP(+) areas containe

41 graphic interpretations were correlated with surgical pathology or clinical diagnosis.

42 Surgical pathology or long-term follow-up (median, 24 mo

43 " and "oncocytic neoplasm" and compared with surgical pathology or repeat biopsy results.

44 ncocytomas in 16 of 17 masses (94%) based on surgical pathology or repeat biopsy; four of eight masse

45 ffin 1 antibody, a commonly used antibody in surgical pathology practice; and CPS1 expression appears

46 ective study, all individuals with biopsy or surgical pathology-proven lesions and age-matched contro

47 nic medical records and chart abstraction of surgical, pathology, radiology, and outpatient records,

48 Advances in surgical pathology, refinements in surgical techniques a

49 formalin-fixed, paraffin-embedded and frozen surgical pathology replicates showed the complete preser

50 in within the specimen was identified by the surgical pathology reports and confirmed by re-examinati

51 The AI-generated biopsy and surgical pathology reports had higher mean Flesch Readin

52 itive opinions about AI-generated biopsy and surgical pathology reports, including patient-friendly l

53 Two radiologists blinded to surgical pathology results and clinical outcome evaluate

54 urgery, MRI showed a higher reliability with surgical pathology results for determining the main tumo

55 Preoperative imaging results, surgical pathology results, intraoperative PTH kinetics,

56 study results were correlated with follow-up surgical pathology results.

57 d a false-negative MRI-guided biopsy result (surgical pathology showed <0.02 cm of residual invasive

58 The surgical pathology showed a poorly differentiated adenoc

59 Beyond the exclusion of surgical pathology, signal change and cerebral atrophy v

60 most current assays are invasive, requiring surgical pathology specimens and only informing monochro

61 Surgical pathology specimens from the pancreatic neck we

62 All radiographs and surgical pathology specimens from these lesions were rev

63 ith disease phenotype, using FFPE diagnostic surgical pathology specimens.

64 The overall percent agreement of NCB and surgical pathology to determine tumor grade was poor (ka

65 Surgical pathology was the standard of reference.

66 study, all malignant neoplasms identified on surgical pathology were clinically occult, with surgical